Quinolinic acid-13C4,15N

• UNSPSC Description:

  Quinolinic acid-13C4, 15N is an isotopic labeled Quinolinic acid (HY-100807). Quinolinic acid is an endogenous N-methyl-D-aspartate (NMDA) receptor agonist and has the potential of mediating NMDA neuronal damage and dysfunction[1].

• Target Antigen:

  Endogenous Metabolite

• Type:

  Isotope-Labeled Compounds

• Related Pathways:

  Metabolic Enzyme/Protease

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Inflammation/Immunology; Neurological Disease

• Assay Protocol:

  https://www.medchemexpress.com/quinolinic-acid-13c4-15n.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=[13C]([13C]1=[15N]C=CC=[13C]1[13C](O)=O)O

• Molecular Weight:

  172.08

• References & Citations:

  [1]Heyes MP, et al. Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease. Brain. 1992 Oct;115 ( Pt 5):1249-73.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported